Axon Enterprise, Inc $AXON Stock Bought by StrongBox Wealth LLC

Key Points

• StrongBox Wealth sharply increased its Axon stake in Q3, buying 8,090 shares to reach 8,145 shares valued at about $3.44 million. Hedge funds and other institutions collectively own 79.08% of the stock.
• Analyst sentiment remains positive overall: 14 analysts rate Axon a Buy and three a Hold, resulting in a “Moderate Buy” consensus and an average price target of $688.38.
• Axon’s latest quarter showed revenue growth of 27.8% year over year, but results fell short of expectations: EPS was $1.72 versus a $1.89 estimate, and revenue was $908.55 million versus a $934.33 million estimate.

StrongBox Wealth LLC increased its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 14,709.1% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,145 shares of the biotechnology company's stock after buying an additional 8,090 shares during the quarter. StrongBox Wealth LLC's holdings in Axon Enterprise were worth $3,441,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of AXON. State Street Corp lifted its stake in Axon Enterprise by 5,700.2% during the 2nd quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company's stock valued at $119,724,905,000 after acquiring an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in Axon Enterprise by 18,050.2% during the 2nd quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company's stock worth $7,400,094,000 after acquiring an additional 13,127,348 shares during the last quarter. BlackRock Inc. boosted its holdings in Axon Enterprise by 4.3% during the 2nd quarter. BlackRock Inc. now owns 8,334,551 shares of the biotechnology company's stock worth $4,672,432,000 after acquiring an additional 345,365 shares during the last quarter. Robeco Institutional Asset Management B.V. grew its stake in shares of Axon Enterprise by 391,214.9% in the 3rd quarter. Robeco Institutional Asset Management B.V. now owns 6,988,884 shares of the biotechnology company's stock worth $2,952,943,000 after acquiring an additional 6,987,098 shares in the last quarter. Finally, Assenagon Asset Management S.A. grew its stake in shares of Axon Enterprise by 5,022.8% in the 3rd quarter. Assenagon Asset Management S.A. now owns 4,266,589 shares of the biotechnology company's stock worth $1,802,719,000 after acquiring an additional 4,183,302 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several research firms have commented on AXON. Citigroup reiterated a "market outperform" rating on shares of Axon Enterprise in a research note on Monday. Needham & Company LLC reaffirmed a "buy" rating on shares of Axon Enterprise in a report on Tuesday, October 27th. The Goldman Sachs Group decreased their price target on Axon Enterprise from $715.00 to $675.00 and set a "buy" rating for the company in a research report on Monday, September 21st. UBS Group lifted their price target on Axon Enterprise from $440.00 to $600.00 and gave the stock a "neutral" rating in a report on Thursday, August 6th. Finally, Zacks Research cut Axon Enterprise from a "strong-buy" rating to a "hold" rating in a research report on Tuesday. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Axon Enterprise currently has an average rating of "Moderate Buy" and a consensus price target of $688.38.

Axon Enterprise Price Performance

Axon Enterprise stock opened at $382.56 on Friday. The business's 50 day simple moving average is $447.49 and its 200 day simple moving average is $476.73. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $665.07. The company has a market cap of $31.08 billion, a price-to-earnings ratio of 158.74, a PEG ratio of 8.06 and a beta of 1.48. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.89 by ($0.17). The firm had revenue of $908.55 million during the quarter, compared to analysts' expectations of $934.33 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The business's quarterly revenue was up 27.8% compared to the same quarter last year. During the same period in the prior year, the business earned $1.17 earnings per share. Sell-side analysts forecast that Axon Enterprise, Inc will post 2.10 EPS for the current year.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
• Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
• Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
• Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
• Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit

Insider Transactions at Axon Enterprise

In related news, President Joshua Isner sold 16,775 shares of the business's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the sale, the chief executive officer owned 3,118,012 shares in the company, valued at $1,587,036,927.88. This represents a 0.32% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 37,397 shares of company stock worth $21,234,034 over the last 90 days. 4.20% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.